Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 14.00
Ask: 14.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 14.25
High: 14.25
Low: 14.25
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Thu, 07th Jun 2012 13:59

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cyan's announcement at the end of May that the first Cyan metering partner in India had received a formal request from the TNEB. Airline company Aer Lingus Group has said that its flown passenger load factor in May 2012 increased by 2.9 percentage points on May 2011 to 76.2%. Short haul flown load factor was 73.8%, an increase of 0.9 points on May 2011, with capacity decreasing by 1.6%. Long haul flown load factor was 81.5%, a year-on-year (y/y) increase of 7.4 points, with capacity increasing by 0.5%. The company's flown passengers in May totalled 882,000, a y/y increase of 0.1% compared. Short haul flown passengers in May 2012 were 793,000, a y/y decrease of 1.1%, while long haul flown passengers in May 2012 were 89,000, an increase of 12.7% on May 2011. Aer Lingus Regional's total flown passenger numbers in May 2012 were 88,000, an increase of 33.3% compared to May 2011. Mobile Tornado Group, a provider of instant communication mobile applications to the enterprise market, posted a rise in revenues from £1.4m to £2.0m, while pre-tax loses narrowed to £1.2m (2010: £1.6m). The cost of sales doubled to £0.7m, while basic and diluted losses per share came in at 0.59p, compared to 0.85p the previous year. The company achieved increased sales activity during the year, up 43%, and believes that market within which it operates is increasingly receptive to the proposition it has developed. ANGLE, a technology commercialisation company, has said that its partner, ORIGIO, has received a bid from Cooper Companies, which values ORIGIO at $189m, including debt. Directors and shareholders owning a total of 46% in the company have signed irrevocable undertakings to accept the Cooper offer. The offer represents a 73% premium to the closing price of the shares on June 1st. Cooper has said the combined business will be ranked number one in the IVF market with a 39% market share. If the offer is completed, ORIGIO will continue under the same executive management team and name, operating as an indirect wholly-owned subsidiary of Cooper.Sareum Holdings has conditionally raised £25,000 (before expenses) after placing just over 2.9m shares at 0.85p each. The placing follows a placing made on Wednesday, which raised £0.23m. The company believes that both placings offer the most effective way of providing capital to accelerate its drug discovery programme and to provide working capital for the company. It is expected that the shares will begin trading on June 11th. The company now has around 1.5bn shares in issue.
More News
5 Jun 2024 16:32

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Jun 2024 10:08

Angle unveils plans to raise more than £10m

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

Read more
16 May 2024 20:09

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 May 2024 11:46

Angle reports promising results from Parsortix study

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.